Ovarian response markers | Variable Analyzed | ||||||||
---|---|---|---|---|---|---|---|---|---|
 | Total oocytes collected | ||||||||
 | General population | GnRH agonist group | GnRH antagonist group | ||||||
 | r | 95% CI | P | r | 95% CI | P | r | 95% CI | P |
Age | −0.49 | −0.63 to −0.32 | <0.0001 | −0.44 | −0.62 to −0.20 | 0.0004 | −0.57 | −0.75 to −0.31 | <0.0001 |
AMH | 0.72 | 0.60 to 0.80 | <0.0001 | 0.74 | 0.60 to 0.84 | <0.0001 | 0.70 | 0.50 to 0.83 | <0.0001 |
AFC | 0.72 | 0.61 to 0.81 | <0.0001 | 0.67 | 0.50 to 0.79 | <0.0001 | 0.80 | 0.66 to 0.89 | <0.0001 |
ORPI | 0.78 | 0.68 to 0.84 | <0.0001 | 0.78 | 0.66 to 0.87 | <0.0001 | 0.81 | 0.65 to 0.89 | <0.0001 |
 | MII oocytes | ||||||||
 | General population | GnRH agonist group | GnRH antagonist group | ||||||
 | r | 95% CI | P | r | 95% CI | P | r | 95% CI | P |
Age | −0.51 | −0.64 to −0.34 | <0.0001 | −0.47 | −0.65 to −0.24 | 0.0001 | −0.58 | −0.75 to −0.32 | <0.0001 |
AMH | 0.64 | 0.50 to 0.74 | <0.0001 | 0.69 | 0.52 to 0.80 | <0.0001 | 0.61 | 0.37 to 0.78 | <0.0001 |
AFC | 0.64 | 0.50 to 0.74 | <0.0001 | 0.59 | 0.40 to 0.74 | <0.0001 | 0.69 | 0.51 to 0.84 | <0.0001 |
ORPI | 0.70 | 0.57 to 0.78 | <0.0001 | 0.74 | 0.59 to 0.83 | <0.0001 | 0.70 | 0.48 to 0.83 | <0.0001 |
 | Follicles ≥10 mm | ||||||||
 | General population | GnRH agonist group | GnRH antagonist group | ||||||
 | r | 95% CI | P | r | 95% CI | P | r | 95% CI | P |
Age | −0.50 | −0.64 to −0.33 | <0.0001 | −0.44 | −0.62 to −0.20 | 0.0005 | −0.60 | −0.77 to −0.35 | <0.0001 |
AMH | 0.77 | 0.67 to 0.84 | <0.0001 | 0.80 | 0.68 to 0.88 | <0.0001 | 0.77 | 0.61 to 0.88 | <0.0001 |
AFC | 0.76 | 0.65 to 0.83 | <0.0001 | 0.76 | 0.62 to 0.85 | <0.0001 | 0.79 | 0.63 to 0.88 | <0.0001 |
ORPI | 0.82 | 0.74 to 0.87 | <0.0001 | 0.86 | 0.76 to 0.91 | <0.0001 | 0.81 | 0.72 to 0.91 | <0.0001 |
 | Follicles ≥16 mm | ||||||||
 | General population | GnRH agonist group | GnRH antagonist group | ||||||
 | r | 95% CI | P | r | 95% CI | P | r | 95% CI | P |
Age | −0.51 | −0.65 to −0.35 | <0.0001 | −0.46 | −0.64 to −0.23 | 0.0002 | −0.62 | −0.78 to −0.38 | <0.0001 |
AMH | 0.60 | 0.45 to 0.71 | <0.0001 | 0.65 | 0.47 to 0.78 | <0.0001 | 0.58 | 0.33 to 0.76 | <0.0001 |
AFC | 0.61 | 0.46 to 0.72 | <0.0001 | 0.64 | 0.45 to 0.77 | <0.0001 | 0.61 | 0.42 to 0.80 | <0.0001 |
ORPI | 0.67 | 0.53 to 0.76 | <0.0001 | 0.72 | 0.56 to 0.82 | <0.0001 | 0.67 | 0.45 to 0.81 | <0.0001 |
 | Follicles ≥18 mm | ||||||||
 | General population | GnRH agonist group | GnRH antagonist group | ||||||
 | r | 95% CI | P | r | 95% CI | P | r | 95% CI | P |
Age | −0.44 | −0.59 to −0.26 | <0.0001 | −0.35 | −0.56 to −0.10 | 0.0053 | −0.66 | −0.81 to −0.44 | <0.0001 |
AMH | 0.50 | 0.33 to 0.63 | <0.0001 | 0.50 | 0.31 to 0.69 | <0.0001 | 0.56 | 0.30 to 0.74 | 0.0001 |
AFC | 0.52 | 0.35 to 0.65 | <0.0001 | 0.52 | 0.32 to 0.70 | <0.0001 | 0.62 | 0.38 to 0.78 | <0.0001 |
ORPI | 0.56 | 0.40 to 0.68 | <0.0001 | 0.56 | 0.37 to 0.72 | <0.0001 | 0.65 | 0.42 to 0.80 | <0.0001 |